Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus egui-induced pneumonia

American Journal of Veterinary Research

Volumn 62, Issue 8, 2001, Pages 1307-1313

  Hooper McGrevy, Kathleen E ^a   Giguere, Steve ^a,b   Wilkie, Bruce N ^a   Prescott, John F ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE; RHODOCOCCUS; RHODOCOCCUS EQUI;

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; FIBRINOGEN; IMMUNOGLOBULIN; LIPOPROTEIN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; VAPC PROTEIN, DICHELOBACTER NODOSUS; VIRULENCE FACTOR;

ANIMAL; ANIMAL DISEASE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BLOOD; BODY TEMPERATURE; BREATHING; HEART RATE; HORSE; HORSE DISEASE; IMMUNOLOGY; LEUKOCYTE COUNT; LUNG; MALE; MICROBIOLOGY; RANDOMIZATION; RHODOCOCCUS EQUI; VIROLOGY;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; BODY TEMPERATURE; FIBRINOGEN; HEART RATE; HORSE DISEASES; HORSES; IMMUNOGLOBULINS; LEUKOCYTE COUNT; LIPOPROTEINS; LUNG; MALE; MEMBRANE GLYCOPROTEINS; PNEUMONIA, BACTERIAL; RANDOM ALLOCATION; RECOMBINANT PROTEINS; RESPIRATION; RHODOCOCCUS EQUI; VIRULENCE FACTORS;

EID: 0035434153     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.1307     Document Type: Review

References (43)

1. Zink MC, Yager JA, Smart NL. Corynebacterium equi infections in horses, 1958-1994: a review of 131 cases. Can Vet J 1986;27:213-217.
2. Hillidge CJ. Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Vet Microbiol 1987;14: 337-342.
3. Martens RJ, Martens JG, Fiske PF. Rhodococcus equi foal pneumonia: pathogenesis and immunoprophylaxis, in Proceedings. 35th Annu Meet Am Assoc Equine Pract 1989;199-213.
4. Martens RJ, Martens JG, Fiske PF, et al. Rhodococcus equi foal pneumonia: protective effect of immune plasma in experimentally infected foals. Equine Vet J 1989;21:249-255.
5. Madigan JE, Hietala S, Muller N. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma. J Reprod Fertil Suppl 1991;44:571-578.
6. Higuchi T, Arakawa T, Hashikura S, et al. Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection in foals from endemically affected farms. Zentrabl Veterinarmed [B] 1999;46:641-648.
7. Hietala SK, Ardans AA, Sansome A. Detection of Corynebacterium equi-specific antibody in horses by enzyme-linked immunosorbent assay. Am J Vet Res 1985;46:13-15.
8. Prescott JF. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev 1991;4:20-34.
9. Hietala SK, Ardans AA. Interaction of Rhodococcus equi with phagocytic cells from Rhodococcus equi-exposed and non-exposed foals. Vet Microbiol 1987;14:307-320.
10. Martens RJ, Martens JG, Renshaw HW, et al. Rhodococcus equi: neutrophil chemiluminescent and bactericidal responses to opsonizing antibody. Vet Microbiol 1987;14:277-286.
11. Nordmann P, Ronco E, Nauciel C. Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun 1992;60:2748-2752.
12. Tan C, Prescott JF, Patterson MC, et al. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity. Can J Vet Res 1995;59:51-59.
13. Darji A. Neutralizing monoclonal antibodies against listeriolysin: mapping of epitopes involved in pore formation. Infect Immun 1996;64:2356-2358.
14. Gambrill MR, Wissman CL. Mechanisms of immunity in typhus infections. 3. Influence of human immune serum and complement on the fate of Rickettsia mooseri within the human macrophages. Infect Immun 1973;8:631-640.
15. Michetti P. Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology 1994;107:915-923.
16. Frank MM, Joiner K, Hammer C. The function of antibody and complement in the lysis of bacteria. Rev Infect Dis 1987;9: S537-S545.
17. Pal S, Theodor I, Peterson EM, et al. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 1997;15:575-582.
18. Ando S, Takashima I, Hashimoto N. Neutralization of Chlamydia psittaci with monoclonal antibodies. Microbiol Immunol 1993;37:753-758.
19. Horwitz MA, Silverstein SC. Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement. J Exp Med 1981;153:386-397.
20. Messick JB, Rikihisa Y. Inhibition of binding, entry, or intracellular proliferation of Ehrlichia risticii in P388D1 cells by anti-E. risticii serum, immunoglobulin G, or Fab fragment. Infect Immun 1994;62:3156-3161.
21. Lee E, Rikihisa Y. Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of IκB-α and activation of NF-κB. Infect Immun 1997;65:2890-2897.
22. Widen RH. Amibody-mediaied enhancement of Legionella pneumophila-induced interleukin 1 activity. Infect Immun 1993;61: 4027-4032.
23. Sekizaki T, Takai S, Egawa Y, et al. Sequence of the Rhodococcus equi gene encoding the virulence associated 15-17-kDa antigens. Gene 1995;155:135-136.
24. Takai S, Sekizaki T, Ozawa T, et al. Association between a large plasmid and 15-to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun 1991;59:4056-4060.
25. Tkachuk-Saad O, Prescott J. Rhodococcus equi plasmids: isolation and partial characterization. J Clin Microbiol 1991;29:2696-2700.
26. Takai S, Mines S, Sekizaki T, et al. DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103. Infect Immun 2000;68:6840-6847
27. Giguère S, Hondalus MK, Yager JA, et al. Role of the 85-kb plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun 1999;67:3548-3557.
28. Wada R, Kamada M, Anzai T, et al. Pathogenicity and virulence of Rhodococcus equi in foals following intratracheal challenge. Vet Microbiol 1997;56:301-312.
29. Hondalus MK, Mosser DM. Survival and replication of Rhodococcus equi in macrophages. Infect Immun 1994;62:4167-4175.
30. Giguere S, Wilkie BN, Prescott JF. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect Immun 1999;67:5041-5047.
31. Prescott JF, Fernandez AS, Nicholson VM, et al. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses. Equine Vet J 1996;28:344-349.
32. Prescott JF, Nicholson VM, Patterson MC, et al. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia. Am J Vet Res 1997;58:356-359.
33. Becu T, Polledo G, Gaskin A. Immunoprophylactic of Rhodococcus equi in foals. Vet Microbiol 1997;56:193-204.
34. + Thl cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect Immun 1996;64:1126-1132.
35. + T-lymphocyte-deficient transgenic mice. Infect Immun 1993;61:4929-4932.
36. Hines SA, Kanaly ST, Byrne BA, et al. Immunity to Rhodococcus equi. Vet Microbiol 1997;56:177-85.
37. Fernandez AS, Prescott JF, Nicholson VM. Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence-associated protein (VapA)-enriched antigens. Vet Microbiol 1997;56:187-192.
38. Chirino-Trejo JM, Prescott JF, Yager JA. Protection of foals against experimental Rhodococcus equi pneumonia by oral immunization. Can J Vet Res 1987;51:444-447.
39. Brumbaugh GW, Davis LE, Thurmon JC, et al. Influence of Rhodococcus equi on the respiratory hurst of resident alveolar macrophages from adult horses. Am J Vet Res 1990;51:766-771.
40. Zink MC, Yager JA, Prescott JF, et al. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol 1987; 14:295-305.
41. Hondalus MK, Diamond MS, Rosenthal LA, et al. The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect Immun 1993;61:2919-2929.
42. Ehlers MRW, Daffė M. Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol 1998;6:329-335.
43. Hurley JR, Begg AP. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust Vet J 1995;72:418-420.